Emily Symington
3PUBLICATIONS
4CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Apr 13, 2026
Final Analysis of the Phase 1/2 Trial of Valoctocogene Roxaparvovec for Severe Haemophilia A.Priyanka Raheja, Savita Rangarajan, Will Lester
|Jul 08, 2024
Valoctocogene roxaparvovec gene therapy provides durable haemostatic control for up to 7 years for haemophilia A.Emily Symington, Savita Rangarajan, Will Lester
|Feb 06, 2024
Long-term safety and efficacy outcomes of valoctocogene roxaparvovec gene transfer up to 6 years post-treatment.Emily Symington, Savita Rangarajan, Will Lester
Pageof 1
